Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial
Cascone T, Kar G, Spicer JD, et al. Cancer Discov. 2023
Cascone T, Kar G, Spicer JD, et al. Cancer Discov. 2023